Valve of inferior vena cava

Valve of inferior vena cava
The valve of the inferior vena cava, also known as the Eustachian valve, is a structure located in the heart. It is a remnant of a fetal structure that directs blood flow from the inferior vena cava (IVC) towards the foramen ovale during fetal development. In adults, the valve is typically non-functional and may be absent or vestigial.
Anatomy[edit]
The valve of the inferior vena cava is situated at the junction where the inferior vena cava enters the right atrium of the heart. It is a thin, crescent-shaped fold of endocardium. In the fetal heart, the Eustachian valve plays a crucial role in directing oxygen-rich blood from the placenta through the foramen ovale into the left atrium, bypassing the non-functional fetal lungs.
Function[edit]
In the fetal circulation, the Eustachian valve helps to ensure that oxygenated blood from the placenta is efficiently delivered to the systemic circulation. After birth, when the foramen ovale closes and the lungs become functional, the valve of the inferior vena cava loses its purpose. In most adults, it remains as a small, non-functional fold of tissue.
Clinical Significance[edit]
While the valve of the inferior vena cava is generally of no clinical significance in adults, it can occasionally be involved in certain medical conditions. For example, it may be mistaken for a pathological structure during echocardiography or other imaging studies. Rarely, it can be associated with right atrial thrombus formation or other cardiac anomalies.
Related Structures[edit]
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian